Lista de obras - Giuseppe D'Eramo - Dominio Público Uruguay

Androgenic and antiandrogenic control on epidermal growth factor, epidermal growth factor receptor, and androgen receptor expression in human prostate cancer cell line LNCaP.

artículo científico publicado en 1995

Comparison between ultrasound-guided and digital-guided anesthesia before prostatic biopsy.

artículo científico publicado en 2012

Cost effectiveness in the management of benign prostatic hyperplasia: Italian data.

artículo científico publicado en 1994

DNA ploidy, Gleason score, pathological stage and serum PSA levels as predictors of disease-free survival in C-D1 prostatic cancer patients submitted to radical retropubic prostatectomy

artículo científico publicado en 1996

Effects of long-term treatment with Serenoa repens (Permixon) on the concentrations and regional distribution of androgens and epidermal growth factor in benign prostatic hyperplasia.

artículo científico publicado en 1998

Evidence that Serenoa repens extract displays an antiestrogenic activity in prostatic tissue of benign prostatic hypertrophy patients

artículo científico publicado en 1992

Incidental prostatic carcinoma: four-year follow-up after treatment with cyproterone acetate

artículo científico publicado en 1990

Is medical therapy an expensive way for delaying surgery in BPH patients?

artículo científico publicado en 1995

Is there always a role for radical prostatectomy in the treatment of localized prostate cancer?

artículo científico publicado en 1995

New ultrasensitive assay development by using monoclonal antibodies for detecting prostate-specific antigen

artículo científico publicado en 1992

Oral ethinylestradiol in castration-resistant prostate cancer: A 10-year experience

artículo científico publicado en 2014

Pathology of BPH.

artículo científico publicado en 1993

Penile metastasis from carcinoma of the prostate in a patient with high serum prostate specific antigen levels

artículo científico publicado en 1999

Plant extracts in BPH.

artículo científico publicado en 1993

Regional distribution of epidermal growth factor, testosterone and dihydrotestosterone in benign prostatic hyperplasia tissue

scientific article published on 01 January 1995

Relationship among age, prostate-specific antigen, and prostate volume in men with lower urinary tract symptoms (LUTS) and in different groups of men with and without benign and malignant prostate diseases.

artículo científico publicado en 1998

Surgery of pulmonary metastases from renal and bladder carcinoma

artículo científico publicado en 1991

The prognostic value of DNA content in patients with prostatic carcinoma

scientific article published on 01 January 1992

The role of hormonal therapy in the treatment of prostatic carcinoma.

artículo científico publicado en 1993

Use of cyclooxygenase-2 inhibitor for prevention of urethral strictures secondary to transurethral resection of the prostate.

artículo científico publicado en 2005

Which patients with prostate cancer are actually candidates for hormone therapy?

artículo científico publicado en 2004

Zoladex vs. Zoladex plus cyproterone acetate in the treatment of advanced prostatic cancer: a multicenter Italian study

scientific article published on 01 January 1990

[A rare case of association of polycystic kidney and hypernephroma]

artículo científico publicado en 1988

[A rare case of single metastasis of papillary carcinoma of the excretory tract treated with surgical therapy only]

artículo científico publicado en 1988

[Comparative effects of transurethral incision (TUIP) and the combination of TUIP and LHRH agonists in the treatment of benign prostatic hypertrophy]

artículo científico publicado en 1996

[Determination of the composition of renal calculi by x-ray spectrometry]

scientific article published on 01 June 1984

[Lymphoma of the testis, epididymis and spermatic cord]

[Pharmacological combinations in the treatment of benign prostatic hypertrophy]

scientific article published on 01 January 1993

[The role of prostate specific antigen and its derivatives (age-specific PSA, PSA density, velocity, free/total PSA) in the diagnosis of prostate cancer]

scientific article published on 01 June 1998

Lista de obras de Giuseppe D'Eramo

Androgenic and antiandrogenic control on epidermal growth factor, epidermal growth factor receptor, and androgen receptor expression in human prostate cancer cell line LNCaP.

Comparison between ultrasound-guided and digital-guided anesthesia before prostatic biopsy.

Cost effectiveness in the management of benign prostatic hyperplasia: Italian data.

DNA ploidy, Gleason score, pathological stage and serum PSA levels as predictors of disease-free survival in C-D1 prostatic cancer patients submitted to radical retropubic prostatectomy

Effects of long-term treatment with Serenoa repens (Permixon) on the concentrations and regional distribution of androgens and epidermal growth factor in benign prostatic hyperplasia.

Evidence that Serenoa repens extract displays an antiestrogenic activity in prostatic tissue of benign prostatic hypertrophy patients

Incidental prostatic carcinoma: four-year follow-up after treatment with cyproterone acetate

Is medical therapy an expensive way for delaying surgery in BPH patients?

Is there always a role for radical prostatectomy in the treatment of localized prostate cancer?

New ultrasensitive assay development by using monoclonal antibodies for detecting prostate-specific antigen

Oral ethinylestradiol in castration-resistant prostate cancer: A 10-year experience

Pathology of BPH.

Penile metastasis from carcinoma of the prostate in a patient with high serum prostate specific antigen levels

Plant extracts in BPH.

Regional distribution of epidermal growth factor, testosterone and dihydrotestosterone in benign prostatic hyperplasia tissue

Relationship among age, prostate-specific antigen, and prostate volume in men with lower urinary tract symptoms (LUTS) and in different groups of men with and without benign and malignant prostate diseases.

Surgery of pulmonary metastases from renal and bladder carcinoma

The prognostic value of DNA content in patients with prostatic carcinoma

The role of hormonal therapy in the treatment of prostatic carcinoma.

Use of cyclooxygenase-2 inhibitor for prevention of urethral strictures secondary to transurethral resection of the prostate.

Which patients with prostate cancer are actually candidates for hormone therapy?

Zoladex vs. Zoladex plus cyproterone acetate in the treatment of advanced prostatic cancer: a multicenter Italian study

[A rare case of association of polycystic kidney and hypernephroma]

[A rare case of single metastasis of papillary carcinoma of the excretory tract treated with surgical therapy only]

[Comparative effects of transurethral incision (TUIP) and the combination of TUIP and LHRH agonists in the treatment of benign prostatic hypertrophy]

[Determination of the composition of renal calculi by x-ray spectrometry]

[Lymphoma of the testis, epididymis and spermatic cord]

[Pharmacological combinations in the treatment of benign prostatic hypertrophy]

[The role of prostate specific antigen and its derivatives (age-specific PSA, PSA density, velocity, free/total PSA) in the diagnosis of prostate cancer]